DME is No Longer Exempt from Sales Tax in South Carolina

Published in Government Relations on August 02, 2024

DME providers in South Carolina (SC) have been exempt from paying sales tax to the state of SC since 2007, provided that the items received by a patient 1) are paid for by either the funds of Medicare of South Carolina Medicaid, 2) are sold by a provider who holds a South Carolina retail sales license and 3) are provided by a supplier whose principal place of business is located in South Carolina, and 4) meet the definition of DME. The language of that tax exemption can be found in S.C. code 12-36-2120(74).

In a June 26, 2024 ruling, the Supreme Court of South Carolina determined that the provision which exempts DME from being subject to sales tax in SC to be unconstitutional, arguing that the language of the original sales tax exemption was unfair and discriminatory against interstate commerce. Under the existing exemption language, out-of-state providers were required to pay sales tax while in-state providers were not. The Court found that the existing exemption language violated the Commerce Clause, and therefore should be stricken and removed altogether from the current code.

Some important takeaways for providers who offer products and services in South Carolina include:

  1. DME sales after June 26, 2024 are subject to sales tax, and all providers, in state or out of state, will need to collect and/or remit sales tax (6%) to the state on the DME sales transactions in South Carolina which occur after that date.
  2. The SC Supreme Court said they are open to allowing a new sales tax exemption to be passed and implemented in the state, it would just have to be worded differently than the previous language that was just voided. Working alongside SC providers and other industry stakeholders, VGM can certainly assist in drafting new tax exemption language in the hopes of getting it through the legislative process and ultimately passed and implemented. That process will take some time (possibly 1-2 years).
  3. Providers who are based outside of South Carolina, and who have been paying taxes all along, could be eligible for a refund from the state of SC. In their ruling and subsequent informational letter, the SC Supreme Court affirmed a circuit court’s previous decision to issue refunds to out-of-state providers who had paid sales tax into the state on their DME sales. Providers interested in requesting a refund can use Form ST-14 to initiate that process.

The removal of the tax exemption for DME will certainly impact DME providers who do business in South Carolina. We will strive to get a new exemption established going forward. In the meantime, providers can certainly have discussions with their payer sources, including Medicaid, Medicaid MCOs, private payers, etc. regarding what the removal of the exemption means to their business and what needs to happen to offset the impact of this change. If providers can’t afford to absorb the additional costs incurred by this change, they may need to request a fee schedule or process adjustments to offset these additional costs.

VGM will continue to monitor this change and will update you regarding any additional changes or information that comes to light regarding the removal of the sales tax exemption for DME in South Carolina. Additional information regarding this topic can also be found in Informational Letter 24-10.


TAGS

  1. billing & reimbursement
  2. dmepos
  3. regulatory
  4. vgm government

From Our Experts

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement. The Return of Competitive Bidding thumbnail The Return of Competitive Bidding The Centers for Medicare & Medicaid Services (CMS) appear to be laying the groundwork for another round of the Competitive Bidding Program (CBP). While full implementation will take a couple of years, an official announcement is expected this summer—potentially as early as July. Out With The Old RAC, In With The New thumbnail Out With The Old RAC, In With The New On April 28, 2025, CMS awarded Cotiviti GOV Services LLC, the new RAC Recovery Audit Contractor (RAC) Region 3, 4, and 5 contracts. RAC Region 3 includes the following Medicare Administrative Contractor (MAC) jurisdictions: JJ, JM, and JN. RAC Region 4 includes jurisdictions: JE, JF, and JL. And RAC Region 5 includes jurisdictions: JA, JB, JC, JD, as well as the HH/H MACs: J6, J15, JK, and JM.